A deletion at ADAMTS9-MAGI1 locus is associated with psoriatic arthritis risk. Issue 10 (19th May 2015)

• Record Type: Journal Article
• Authors: Julià, Antonio; Pinto, José Antonio; Gratacós, Jordi; Queiró, Rubén; Ferrándiz, Carlos; Fonseca, Eduardo; Montilla, Carlos; Torre-Alonso, Juan Carlos; Puig, Lluís; Pérez Venegas, José Javier; Fernández Nebro, Antonio; Fernández, Emilia; Muñoz-Fernández, Santiago; Daudén, Esteban; González, Carlos; Roig, Daniel; Sánchez Carazo, José Luís; Zarco, Pedro; Erra, Alba; López Estebaranz, José Luís; Rodríguez, Jesús; Ramírez, David Moreno; de la Cueva, Pablo; Vanaclocha, Francisco; Herrera, Enrique; Castañeda, Santos; Rubio, Esteban; Salvador, Georgina; Díaz-Torné, César; Blanco, Ricardo; Willisch Domínguez, Alfredo; Mosquera, José Antonio; Vela, Paloma; Tornero, Jesús; Sánchez-Fernández, Simón; Corominas, Héctor; Ramírez, Julio; López-Lasanta, María; Tortosa, Raül; Palau, Nuria; Alonso, Arnald; García-Montero, Andrés C; Gelpí, Josep Lluís; Codó, Laia; Day, Kenneth; Absher, Devin; Myers, Richard M; Cañete, Juan D; Marsal, Sara;
• Is Part Of: Annals of the rheumatic diseases. Volume 74:Issue 10(2015)
• Page Start: 1875
• Page End: 1881
• Publication Date: 2015-05-19
• Subjects: Psoriatic Arthritis -- Gene Polymorphism -- Epidemiology -- Arthritis; Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2014-207190
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Objective: Copy number variants (CNVs) have been associated with the risk to develop multiple autoimmune diseases. Our objective was to identify CNVs associated with the risk to develop psoriatic arthritis (PsA) using a genome-wide analysis approach. Methods: A total of 835 patients with PsA and 1498 healthy controls were genotyped for CNVs using the Illumina HumanHap610 BeadChip genotyping platform. Genomic CNVs were characterised using CNstream analysis software and analysed for association using the χ 2 test. The most significant genomic CNV associations with PsA risk were independently tested in a validation sample of 1133 patients with PsA and 1831 healthy controls. In order to test for the specificity of the variants with PsA aetiology, we also analysed the association to a cohort of 822 patients with purely cutaneous psoriasis (PsC). Results: A total of 165 common CNVs were identified in the genome-wide analysis. We found a highly significant association of an intergenic deletion between ADAMTS9 and MAGI1 genes on chromosome 3p14.1 (p=0.00014). Using the independent patient and control cohort, we validated the association between ADAMTS9-MAGI1 deletion and PsA risk (p=0.032). Using next-generation sequencing, we characterised the 26 kb associated deletion. Finally, analysing the PsC cohort we found a lower frequency of the deletion compared with the PsA cohort (p=0.0088) and a similar frequency to that of healthy controls (p>0.3). Conclusions: The present genome-wide scan for CNVs associated with PsA risk has identified a new deletion associated with disease risk and which is also differential from PsC risk.